logo
15:59 May 19

Laurus Labs Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
1344.90
+17.60 (+1.33%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Laurus Labs Ltd. Financials

Laurus Labs Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
1344.90
+17.60 (+1.33%)
15:59 May 19
Quality
image/svg+xml

86/100
High Financial Strength

Valuation
image/svg+xml

32/100
Mid Valuation

Technical

67/100
Technically Moderately Bullish

Strength

15

Weakness

3

Opportunity

1

Threats

0

16.76 %

ROE %

8.45 %

ROA %

16.46

EPS

98.18

BVPS

13.04 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Net Sales
4935.57 6040.55 5040.83 5553.96 6812.9
Operating Expenses +
3513.14 4448.36 4263.33 4498.68 5035.19
Raw Material
2414.94 2752.28 2533.3 2533.91 2966.9
Increase Decrease in Cost
-221.17 22.04 -100.88 -55.93 -271.44
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
501.53 580.64 639.93 719.52 895.45
Miscellaneous Expenses
1109.46 1404.82 1412.82 1511.9 1789.4
Operating Profit
1422.43 1592.19 777.5 1055.28 1777.71
Other Income
13.58 6 26.34 59.93 54.95
Depreciation
251.49 324.08 384.58 430.09 480.05
Interest
100.67 165.17 182.9 200.83 170.73
Profit before tax and exceptio..
1083.85 1108.94 236.36 484.29 1181.88
Exceptional Items
0 0 0 0 0
PBT
1083.85 1108.94 236.36 484.29 1181.88
Provision for Taxation
251.42 312.3 68.15 129.88 292.03
Net Profit
832.43 796.64 168.21 354.41 889.85
NET Profit after MI
827.52 790.11 160.55 358.32 888.79
EPS
15.42 14.64 2.97 6.64 16.45
Operating Profit Margin (%)
28.82 26.36 15.42 19 26.09
Net Profit Margin (%)
16.77 13.08 3.19 6.45 13.05

Laurus Labs Ltd. Shareholding

Promoter

FII

Public

All Data in Percentage (%)

Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Promoter 27.50 27.50 27.60 27.60 27.60 27.60
FII 25.80 26.50 26.20 25.70 25.50 25.60
Public 14.00 12.40 11.70 11.90 11.80 12.70
Others 32.70 33.60 34.50 34.80 35.10 34.10
Shareholder Shares Holding %
Research 360 logo
Download Our App On: